USPTO serial 79372086
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey A. Smith
Jeffrey A. Smith Millen, White, Zelano & Branigan, P.C.2200 Clarendon BoulevardSuite 1400Arlington, VA 22201| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological preparations for medical purposes, namely, biological preparations for detecting genetic predispositions for medical purposes; biological preparations for medical purposes, namely, biological preparations for detecting the presence of cancer through blood and body fluid testing; reagent paper for medical purposes; diagnostic biomarker reagents for medical purposes; chemical preparations for detecting genetic predispositions for medical purposes; diagnostic preparations for medical purposes; dietetic substances adapted for medical use, namely, dietetic preparations adapted for medical purposes; dietetic foods and beverages adapted for medical use; diagnostic preparations for veterinary purposes; tissues impregnated with pharmaceutical lotions for use in detecting cancer; tissues impregnated with pharmaceutical lotions for use in blood collection | ACTIVE | — |
| 009 | Data processing apparatus; computer programs, recorded for use with diagnostic devices and testing kits to profile and detect mutations, genetic predispositions and other biomarkers related to the presence of cancer; downloadable computer application software for mobile phones, namely, software for use with diagnostic devices and testing kits to profile and detect mutations, genetic predispositions and other biomarkers related to the presence of cancer; computer software, recorded for use with diagnostic devices and testing kits to profile and detect mutations, genetic predispositions and other biomarkers related to the presence of cancer; computer software applications, downloadable for use with diagnostic devices and testing kits to profile and detect mutations, genetic predispositions and other biomarkers related to the presence of cancer; biometric scanners; electronic agendas; scales; surveying apparatus and instruments; devices in the nature of medical laboratory research instruments for analyzing genome information; diagnostic apparatus for detecting free dna in cancer cells for laboratory or research use, not for medical purposes; diagnostic apparatus for detecting genetic sequences for laboratory or research use, not for medical purposes; laboratory robots; test tubes; optical inspection apparatus | ACTIVE | — |
| 010 | Apparatus for DNA and RNA testing for medical purposes; medical diagnostic apparatus for testing cancer cells and DNA; medical apparatus for detecting cancer; apparatus for use in medical analysis, namely, apparatus for analyzing and identifying cancer cells; apparatus for use in medical analysis, namely, body composition analyzers for medical purposes; electrical stimulation apparatus for nerves, muscles, skin for physical therapy, rehabilitative and pain management purposes; galvanic apparatus for therapeutic purposes, namely, electrotherapy devices for providing transcutaneous electrical nerve stimulation, infrared heat and compression | ACTIVE | — |
| 035 | Advertising services; organization of exhibitions for commercial or advertising purposes; marketing services; personnel recruitment; systemization of information into computer databases; compilation of information into computer databases; updating and maintenance of data in computer databases; business administrative services for medical referrals; sponsorship search | ACTIVE | — |
| 042 | Research and development of new products for others; technological research in the field of medical instruments; scientific laboratory services; product quality testing; chemical analysis; medical and scientific research, namely, conducting clinical trials for others; genetic screening testing, for the purpose of scientific research; structural and functional analysis of genomes; genetic testing for scientific research purposes; blood analysis services; pharmaceutical product evaluation; medical laboratory services; DNA screening for scientific research purposes; conducting early evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; cloud computing featuring software for use in database management, for use as a spreadsheet, for word processing; software as a service (SaaS) services featuring software for use with diagnostic devices and testing kits for detecting mutations, genetic predispositions and other biomarkers related to the presence of cancer; computer programming | ACTIVE | — |
| 044 | Medical assistance; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; telemedicine services; medical equipment rental; health counselling; medical screening; genetic testing for medical purposes; collection and preservation of human blood; beauty salon services; veterinary services; gardening; rental of sanitary installations | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 5, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 5, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 20, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 20, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 31, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 15, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 10, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 10, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 10, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 10, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 2, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 2, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 2, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 31, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 9, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 9, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 27, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 26, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 18, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 12, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 6, 2023 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jun 15, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |